The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gennadios Aristippos since 2015.
This trader's CIK number is 1612357.
At the time of last reporting, Gennadios Aristippos was the Group Pres. Pharma & Consumer of Catalent, Inc.. (stock ticker symbol CTLT).
Also see all insider trading activities at Catalent, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CTLT | 0 | $0 | 1,518 | $90,099 | 0 | $0 |
| 2023 | CTLT | 0 | $0 | 677 | $30,888 | 0 | $0 |
| 2022 | CTLT | 0 | $0 | 2,048 | $212,580 | 0 | $0 |
| 2021 | CTLT | 0 | $0 | 2,837 | $359,799 | 0 | $0 |
| 2020 | CTLT | 0 | $0 | 21,987 | $2,013,203 | 35,917 | $1,040,593 |
| 2019 | CTLT | 0 | $0 | 48,648 | $2,522,497 | 137,408 | $2,092,649 |
| 2015 | CTLT | 0 | $0 | 24,868 | $761,209 | 65,464 | $757,287 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-02 | CTLT | Sale | 1,169 | 59.55 | 69,613 |
| 2024-07-29 | CTLT | Sale | 349 | 58.70 | 20,486 |
| 2023-08-24 | CTLT | Sale | 396 | 44.49 | 17,618 |
| 2023-08-01 | CTLT | Sale | 281 | 47.23 | 13,270 |
| 2022-08-25 | CTLT | Sale | 1,645 | 103.04 | 169,500 |
| 2022-07-26 | CTLT | Sale | 403 | 106.90 | 43,080 |
| 2021-08-27 | CTLT | Sale | 2,262 | 130.75 | 295,745 |
| 2021-07-26 | CTLT | Sale | 465 | 113.05 | 52,568 |
| 2021-01-04 | CTLT | Sale | 110 | 104.42 | 11,486 |
| 2020-12-21 | CTLT | Option Ex | 13,662 | 30.23 | 413,002 |
| 2020-12-21 | CTLT | Sale | 13,662 | 102.88 | 1,405,478 |
| 2020-06-25 | CTLT | Option Ex | 22,255 | 28.20 | 627,591 |
| 2020-06-25 | CTLT | Sale | 8,325 | 73.00 | 607,725 |
| 2019-11-25 | CTLT | Sale | 45,256 | 52.55 | 2,378,202 |
| 2019-11-25 | CTLT | Option Ex | 123,880 | 15.72 | 1,947,765 |
| 2019-03-21 | CTLT | Option Ex | 13,528 | 10.71 | 144,884 |
| 2019-03-21 | CTLT | Sale | 3,392 | 42.54 | 144,295 |
| 2015-04-01 | CTLT | Option Ex | 65,464 | 11.57 | 757,287 |
| 2015-04-01 | CTLT | Sale | 24,868 | 30.61 | 761,209 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gennadios Aristippos (Group Pres. Pharma & Consumer of Catalent, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.